Hypurin Bovine Neutral 100units/ml solution for injection 3ml cartridges

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredjent attiv:

Insulin soluble bovine

Disponibbli minn:

Wockhardt UK Ltd

Kodiċi ATC:

A10AB02

INN (Isem Internazzjonali):

Insulin soluble bovine

Dożaġġ:

100unit/1ml

Għamla farmaċewtika:

Solution for injection

Rotta amministrattiva:

Intramuscular; Intravenous; Subcutaneous

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Caution - AMP level prescribing advised

Sommarju tal-prodott:

BNF: 06010101; GTIN: 5012727904085

Fuljett ta 'informazzjoni

MEASURE BAR SHOULD BE 150MM AT 100% SCALE
Customer
Description
Item Code
Profile
Size
Min. Point Size
Market
Language
Proof By
Proof No.
Date
Artwork No.
Pharma
Code
Colours Used
Wockhardt UK Limited
LFT HYPUR B 100U-ML 3ML CTG COMMON
101973/6
As per uploaded pdf
148 x 350mm
elkie.bramall
2
29/10/2015
607806
123
Process Black
Keylines
[e-mail]
CLEARLY MARK ANY AMENDMENTS ON ONE PROOF AND RETURN TO MPS
WARNING! We cannot accept responsibility for any errors
in this proof after approval. Whilst we take extreme care
at all times to ensure accuracy to our clientʼs brief,
the final responsibility must be taken by our client.
IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING
FULL APPROVAL OF DESIGN AND TEXT.
UK
English
8pt
PACKAGE LEAFLET: INFORMATION FOR THE USER
HYPURIN
® BOVINE RANGE OF INSULIN
INJECTION
READ ALL OF THIS LEAFLET CAREFULLY
BEFORE YOU INJECT YOUR INSULIN.
- Keep this leaflet. You may need to
read it again while you are receiving
your treatment.
- If you have any further questions,
please ask your doctor, pharmacist
or diabetes nurse.
- This medicine has been prescribed
for you. It must not be shared with
other patients. It may harm them
even if their symptoms are the same
as yours.
IN THIS LEAFLET:
1. What Hypurin
®
is and what it is used for
2. Before you receive Hypurin
®
3. How to use Hypurin
®
4. Possible side effects
5. How to store Hypurin
®
6. Further information
1. WHAT HYPURIN
® IS AND WHAT IT IS USED FOR
The name of your medicine is Hypurin Bovine Insulin. Hypurin
Bovine is the brand name for a range of highly purified bovine
(cow) insulin injections.
Hypurin Bovine Neutral is a sterile, clear solution of bovine
insulin (100 international units/ml). It is short acting.
Hypurin Bovine Isophane is a sterile, white suspension of
bovine insulin (100 international units/ml) with protamine
sulphate and zinc chloride in water. It is longer acting than
Hypurin Bovine Neutral.
WHAT HYPURIN IS USED FOR
Hypurin
contains
insulin
which
is
a
natural
hormone,
made by a gland called the

Karatteristiċi tal-prodott

OBJECT 1
HYPURIN BOVINE NEUTRAL CARTRIDGES
Summary of Product Characteristics Updated 19-Jan-2016 | Wockhardt UK
Ltd
1. Name of the medicinal product
Hypurin® Bovine Neutral
2. Qualitative and quantitative composition
Crystalline Insulin Ph Eur (Bovine) 100IU/ml.
Neutral Insulin Injection Ph Eur (Bovine)
For excipients, see 6.1
3. Pharmaceutical form
Solution for injection
A clear, colourless solution
4. Clinical particulars
4.1 Therapeutic indications
The treatment of insulin dependent diabetes mellitus.
May be used for diabetics who require an insulin of prompt onset and
short duration. It is a suitable
preparation for admixture with longer acting insulins. It is
particularly useful where intermittent, short
term or emergency therapy is required, during initial stabilisation
and in the treatment of labile diabetes.
4.2 Posology and method of administration
To be determined by the physician according to the needs of the
patient.
Usually administered subcutaneously but where necessary it may be
given intramuscularly or
intravenously. After subcutaneous injection onset of action occurs
within 30-60 minutes with an overall
duration of 6-8 hours. Maximum effect is exerted over the mid-range.
4.3 Contraindications
Hypoglycaemia.
Hypersensitivity to insulin or to any of the excipients.
4.4 Special warnings and precautions for use
Hypoglycaemia: Susceptibility to hypoglycaemia may be increased by an
inaccurate or excessive dosage
of insulin, the omission of a meal by the patient or increased
physical activity. Correct insulin
administration and awareness of the symptoms of hypoglycaemia are
essential to reduce the risk of
hypoglycaemia (see section 4.9).
Blood or urinary glucose concentrations should be monitored and the
urine tested for ketones by patients
on insulin therapy.
Newly diagnosed diabetic patients may experience fluctuating insulin
requirements during the first weeks,
months or even years of treatment (the so-called 'honeymoon period').
Patients transferred to Hypurin® Bovine insulins from other
commerci